Sign in

Private company

Atreca, Inc.

American pharmaceutical preparations company based in Redwood City2

In its 2023 annual report the company says: “We are a clinical-stage biopharmaceutical company utilizing our differentiated platform primarily to discover and develop novel antibody-based therapeutics to treat a range of solid tumor types. We have utilized our drug discovery approach to identify over 2,000 distinct human antibodies that bind preferentially to tumor tissue from patients who are not the source of the antibody.”49

Last updated Oct 21, 2026.

Overview

-$97.2MNet income, fiscal 20223
  • IndustryPharmaceutical Preparations2
  • HeadquartersRedwood City, United States2
  • Incorporated inDE4
  • Business address835 Industrial Road,, Suite 400, San Carlos, Ca 940704
  • Filer category, Emerging growth company4
  • Legal formCorporation2
  • LEI549300B5CQV1OOXFLU712
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O NATIONAL REGISTERED AGENTS, INC., 19801 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 48355572

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-123.9%Return on equity3
-$81.6MFree cash flow3

Financial statements

Net income5673-$97.2M in 2022+156% since 2018
-$150.0M-$100.0M-$50.0M02018: -$37.9M-$37.9M20182019: -$67.5M-$67.5M2019+78%2020: -$86.3M-$86.3M2020+28%2021: -$109.3M-$109.3M2021+27%2022: -$97.2M-$97.2M2022−11%
Fiscal year201720182019202020212022
Research and development$32.5M5$54.7M6$62.0M7$78.3M3$66.8M3
Operating expenses$110.3M3$98.7M3
Interest$9.0K5$6.0K6$4.0K7$3.0K3
Income before tax-$109.3M3-$97.2M3
Income tax-$1.0K5$1.0K6$1.0K7$1.0K3
Net income-$37.9M5-$67.5M6-$86.3M7-$109.3M3-$97.2M3
Earnings per share-$2.707-$2.953-$2.523
Earnings per share (diluted)-$2.707-$2.953-$2.523
Shares (weighted, basic)37.0M shares338.6M shares3
Shares (weighted, diluted)37.0M shares338.6M shares3

Compare Atreca, Inc. with another company

Corporate structure

Atreca, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Atreca, Inc.

  • Atreca, Inc. Redwood City, California, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Atreca, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$54.7M3 Dec 31, 2022$54.3M3 Dec 31, 2021+0.7%
Accumulated depreciation$16.8M3 Dec 31, 2022$11.3M3 Dec 31, 2021+48.1%
Property and equipment, net$38.0M3 Dec 31, 2022$43.0M3 Dec 31, 2021−11.7%
Operating-lease assets (leased space)$36.1M3 Dec 31, 2022

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$30.8M3 Dec 31, 2022$94.7M3 Dec 31, 2021−67.5%
Marketable securities, current$39.7M3 Dec 31, 2022$22.3M3 Dec 31, 2021+78.0%
Long-term investments$31.0M3 Dec 31, 2021$10.8M6 Dec 31, 2019+187.5%

Leadership

Who has led Atreca, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. John A. Orwin2019–2024

President

  1. John A. Orwin2019–2024

Chief financial officer

  1. Herb Cross2019–2023
20202025
Board members and other officers (17)

Timeline

  1. Mar 11, 20248-K Listing notice or transfer28
  2. Feb 6, 20248-K Executive or director change29
  3. Dec 26, 20238-K Entered a material agreement; Executive or director change; Regulation FD disclosure30
  4. Nov 14, 20238-K Results of operations31
  5. Sep 21, 20238-K Ended a material agreement; Executive or director change; Regulation FD disclosure32
  6. Sep 14, 20238-K Listing notice or transfer33
  7. Aug 10, 20238-K Results of operations; Exit or restructuring costs34
  8. Jun 15, 20238-K Shareholder vote35
  9. May 10, 20238-K Results of operations36
  10. Mar 29, 20238-K Results of operations37
  11. Nov 10, 20228-K Results of operations38
  12. Aug 8, 20228-K Results of operations39
  13. Jun 19, 2019New chief executive John A. Orwin becomes CEO11
  14. Jun 11, 2010Founded Atreca, Inc. is founded2

Calendar

When it reported results

  1. Nov 14, 2023Reported quarterly or annual results31
  2. Aug 10, 2023Reported quarterly or annual results34
  3. May 10, 2023Reported quarterly or annual results36
  4. Mar 29, 2023Reported quarterly or annual results37
  5. Nov 10, 2022Reported quarterly or annual results38
  6. Aug 8, 2022Reported quarterly or annual results39
  7. May 11, 2022Reported quarterly or annual results40
  8. Mar 3, 2022Reported quarterly or annual results41

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

121 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 19 major events, 50 insider forms, 9 large holders, 34 other. The latest 20:

  1. Apr 22, 2024DEFM14A EDGAR
  2. Apr 17, 20244 EDGAR
  3. Apr 11, 2024PREM14A EDGAR
  4. Apr 3, 20244 EDGAR
  5. Apr 3, 20244 EDGAR
  6. Apr 3, 20244 EDGAR
  7. Apr 3, 20244 EDGAR
  8. Apr 1, 202415-12G EDGAR
  9. Apr 1, 2024S-8 POS EDGAR
  10. Apr 1, 2024S-8 POS EDGAR
  11. Apr 1, 2024S-8 POS EDGAR
  12. Apr 1, 2024S-8 POS EDGAR
  13. Apr 1, 2024S-8 POS EDGAR
  14. Mar 29, 2024DEFA14A EDGAR
  15. Mar 26, 2024DEFA14A EDGAR
  16. Mar 22, 2024EFFECT EDGAR
  17. Mar 22, 2024EFFECT EDGAR
  18. Mar 22, 2024POS AM EDGAR
  19. Mar 22, 2024POS AM EDGAR
  20. Mar 20, 202425 EDGAR

The 121 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

16 open-market trades by officers, directors and large owners since October 2021: 1 buys and 15 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Apr 11, 2024Orwin John APRESIDENT & CEOBuy1$0.01Form 4
Apr 1, 2024Serafini TitoDirectorSale20,788$0.07$1.5KForm 4
Oct 19, 2023BAKER JULIANSale274,739$0.40$109.9KForm 4
Sep 1, 2023Orwin John APRESIDENT & CEOSale22,951$0.37$8.5KForm 4
Sep 1, 2023Serafini TitoDirectorSale8,393$0.37$3.1KForm 4
Sep 1, 2023Courtney PhillipsGENERAL COUNSEL & SECRETARYSale7,061$0.37$2.6KForm 4
Aug 2, 2023Serafini TitoDirectorSale5,487$0.95$5.2KForm 4
Aug 2, 2023CROSS HERBChief Financial OfficerSale5,487$0.95$5.2KForm 4
Aug 2, 2023Gould Stephen EChief Scientific OfficerSale4,076$0.95$3.9KForm 4
Aug 2, 2023Courtney PhillipsGENERAL COUNSEL & SECRETARYSale4,076$0.95$3.9KForm 4
Sep 2, 2022Serafini TitoDirectorSale7,646$1.78$13.6KForm 4
Sep 2, 2022Orwin John APRESIDENT & CEOSale20,908$1.78$37.2KForm 4
Sep 2, 2022CROSS HERBChief Financial OfficerSale7,646$1.78$13.6KForm 4
Sep 2, 2022Courtney PhillipsGENERAL COUNSEL & SECRETARYSale6,432$1.78$11.4KForm 4
Jun 28, 2022Serafini TitoDirectorSale15,000$2.02$30.3KForm 4
Mar 4, 2022Serafini TitoDirectorSale30,000$5.00$150.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Atreca, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAtreca, Inc.1
  • CIK0001532346
  • Employer ID (EIN)27-37232551
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address835 Industrial Road,, Suite 400, San Carlos, CA 940701
  • Phone650-595-25951
  • Public float$48.8M as of Jun 30, 20223
  • On EDGAR sinceOct 18, 20111
  • Filings341 in all: 4 (152), 8-K (42), 3 (23), SC 13G/A (18), 10-Q (14), D (10), CORRESP (9), SC 13G (9)1
    All 34 form types

    DEFA14A (8), EFFECT (6), S-8 (5), S-8 POS (5), 10-K (4), 424B5 (4), DEF 14A (4), UPLOAD (4), S-3 (3), 424B3 (2), DEFM14A (2), POS AM (2), PREM14A (2), 10-K/A (1), 15-12G (1), 25 (1), 4/A (1), 424B4 (1), 8-A12B (1), ARS (1), CERT (1), D/A (1), DRS (1), S-1 (1), S-1/A (1), S-3/A (1)

  • Latest filingsAnnual report (10-K) Mar 29, 2023
    Quarterly report (10-Q) Nov 14, 2023
    Proxy statement (DEF 14A) Apr 27, 2023
    Latest 8-K (8-K) Mar 11, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49